English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 122 | Tables: 130 | Service & Software
In 2024, the global market size of Blockchain In Pharmaceutical was estimated to be worth US$ 4667 million and is forecast to reach approximately US$ 96750 million by 2031 with a CAGR of 55.0% during the forecast period 2025-2031.
Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.
Market Drivers
1. Supply Chain Transparency and Traceability
Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.
2. Counterfeit Drug Prevention
Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.
3. Regulatory Compliance
Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.
4. Improved Drug Recall Management
In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.
5. Enhanced Data Security and Privacy
Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blockchain In Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blockchain In Pharmaceutical.
The Blockchain In Pharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blockchain In Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blockchain In Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
IBM
AWS
Microsoft
SAP
Chronicled
Embleema
FarmaTrust
Guardtime Federal
Segment by Type
Private Blockchain
Hybrid Blockchain
Segment by Application
Supply Chain Logistics
Drug Safety
Clinical Trial Management
IOMT & Cyber Security
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Blockchain In Pharmaceutical in global and regional level.
Chapter 3: Detailed analysis of Blockchain In Pharmaceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blockchain In Pharmaceutical revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Blockchain In Pharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Blockchain In Pharmaceutical Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Private Blockchain
1.2.3 Hybrid Blockchain
1.3 Market by Application
1.3.1 Global Blockchain In Pharmaceutical Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Supply Chain Logistics
1.3.3 Drug Safety
1.3.4 Clinical Trial Management
1.3.5 IOMT & Cyber Security
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blockchain In Pharmaceutical Market Size Estimates and Forecasts
2.2 Blockchain In Pharmaceutical Market Size by Region: 2024 Versus 2031
2.2.1 Global Blockchain In Pharmaceutical Revenue by Region: 2020-2025
2.2.2 Global Blockchain In Pharmaceutical Revenue Forecast by Region (2026-2031)
2.2.3 Global Blockchain In Pharmaceutical Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Blockchain In Pharmaceutical Revenue by Type (2020-2031)
3.1.2 Global Blockchain In Pharmaceutical Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Blockchain In Pharmaceutical Revenue by Application (2020-2031)
3.2.2 Global Blockchain In Pharmaceutical Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Private Blockchain of Blockchain In Pharmaceutical Revenue Market Share by Application
3.3.2 Hybrid Blockchain of Blockchain In Pharmaceutical Revenue Market Share by Application
4 Global Blockchain In Pharmaceutical by Company
4.1 Global Blockchain In Pharmaceutical Revenue by Company (2020-2025)
4.2 Global Blockchain In Pharmaceutical Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Blockchain In Pharmaceutical Companies around the World: Ranking by Revenue
4.3.2 Global Blockchain In Pharmaceutical Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Blockchain In Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Blockchain In Pharmaceutical Companies Headquarters & Product Type
4.4.1 Global Blockchain In Pharmaceutical Companies Headquarters
4.4.2 Date of International Companies Enter into Blockchain In Pharmaceutical Market
4.4.3 Global Blockchain In Pharmaceutical Companies Product & Service
4.4.4 Private Blockchain Revenue Market Share of Blockchain In Pharmaceutical by Company
4.4.5 Hybrid Blockchain Revenue Market Share of Blockchain In Pharmaceutical by Company
4.5 Global Blockchain In Pharmaceutical Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 IBM
5.1.1 IBM Corporation Information
5.1.2 IBM Description, Business Overview
5.1.3 IBM Blockchain In Pharmaceutical Products Offered
5.1.4 IBM Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.1.5 IBM Blockchain In Pharmaceutical Revenue by Product in 2024
5.1.6 IBM Blockchain In Pharmaceutical Revenue by Application in 2024
5.1.7 IBM Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.1.8 IBM Recent Developments
5.2 AWS
5.2.1 AWS Corporation Information
5.2.2 AWS Description, Business Overview
5.2.3 AWS Blockchain In Pharmaceutical Products Offered
5.2.4 AWS Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.2.5 AWS Blockchain In Pharmaceutical Revenue by Product in 2024
5.2.6 AWS Blockchain In Pharmaceutical Revenue by Application in 2024
5.2.7 AWS Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.2.8 AWS Recent Developments
5.3 Microsoft
5.3.1 Microsoft Corporation Information
5.3.2 Microsoft Description, Business Overview
5.3.3 Microsoft Blockchain In Pharmaceutical Products Offered
5.3.4 Microsoft Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.3.5 Microsoft Blockchain In Pharmaceutical Revenue by Product in 2024
5.3.6 Microsoft Blockchain In Pharmaceutical Revenue by Application in 2024
5.3.7 Microsoft Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.3.8 Microsoft Recent Developments
5.4 SAP
5.4.1 SAP Corporation Information
5.4.2 SAP Description, Business Overview
5.4.3 SAP Blockchain In Pharmaceutical Products Offered
5.4.4 SAP Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.4.5 SAP Blockchain In Pharmaceutical Revenue by Product in 2024
5.4.6 SAP Blockchain In Pharmaceutical Revenue by Application in 2024
5.4.7 SAP Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.4.8 SAP Recent Developments
5.5 Chronicled
5.5.1 Chronicled Corporation Information
5.5.2 Chronicled Description, Business Overview
5.5.3 Chronicled Blockchain In Pharmaceutical Products Offered
5.5.4 Chronicled Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.5.5 Chronicled Blockchain In Pharmaceutical Revenue by Product in 2024
5.5.6 Chronicled Blockchain In Pharmaceutical Revenue by Application in 2024
5.5.7 Chronicled Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.5.8 Chronicled Recent Developments
5.6 Embleema
5.6.1 Embleema Corporation Information
5.6.2 Embleema Description, Business Overview
5.6.3 Embleema Blockchain In Pharmaceutical Products Offered
5.6.4 Embleema Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.6.5 Embleema Blockchain In Pharmaceutical Revenue by Product in 2024
5.6.6 Embleema Blockchain In Pharmaceutical Revenue by Application in 2024
5.6.7 Embleema Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.6.8 Embleema Recent Developments
5.7 FarmaTrust
5.7.1 FarmaTrust Corporation Information
5.7.2 FarmaTrust Description, Business Overview
5.7.3 FarmaTrust Blockchain In Pharmaceutical Products Offered
5.7.4 FarmaTrust Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.7.5 FarmaTrust Blockchain In Pharmaceutical Revenue by Product in 2024
5.7.6 FarmaTrust Blockchain In Pharmaceutical Revenue by Application in 2024
5.7.7 FarmaTrust Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.7.8 FarmaTrust Recent Developments
5.8 Guardtime Federal
5.8.1 Guardtime Federal Corporation Information
5.8.2 Guardtime Federal Description, Business Overview
5.8.3 Guardtime Federal Blockchain In Pharmaceutical Products Offered
5.8.4 Guardtime Federal Blockchain In Pharmaceutical Revenue and Gross Margin (2020-2025)
5.8.5 Guardtime Federal Blockchain In Pharmaceutical Revenue by Product in 2024
5.8.6 Guardtime Federal Blockchain In Pharmaceutical Revenue by Application in 2024
5.8.7 Guardtime Federal Blockchain In Pharmaceutical Revenue by Geographic Area in 2024
5.8.8 Guardtime Federal Recent Developments
6 North America
6.1 North America Blockchain In Pharmaceutical Market Size YoY Growth 2020-2031
6.2 North America Blockchain In Pharmaceutical Market Facts & Figures by Country (2020-2031)
6.3 North America Blockchain In Pharmaceutical Revenue by Type (2020-2025)
6.4 North America Blockchain In Pharmaceutical Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Blockchain In Pharmaceutical Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Blockchain In Pharmaceutical Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Blockchain In Pharmaceutical Revenue by Type (2020-2025)
7.4 Asia-Pacific Blockchain In Pharmaceutical Revenue by Application (2020-2025)
8 Europe
8.1 Europe Blockchain In Pharmaceutical Market Size YoY Growth 2020-2031
8.2 Europe Blockchain In Pharmaceutical Market Facts & Figures by Country (2020-2031)
8.3 Europe Blockchain In Pharmaceutical Revenue by Type (2020-2025)
8.4 Europe Blockchain In Pharmaceutical Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Blockchain In Pharmaceutical Market Size YoY Growth 2020-2031
9.2 Latin America Blockchain In Pharmaceutical Market Facts & Figures by Country (2020-2031)
9.3 Latin America Blockchain In Pharmaceutical Revenue by Type (2020-2025)
9.4 Latin America Blockchain In Pharmaceutical Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Blockchain In Pharmaceutical Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Blockchain In Pharmaceutical Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Blockchain In Pharmaceutical Revenue by Type (2020-2025)
10.4 Middle East and Africa Blockchain In Pharmaceutical Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Blockchain In Pharmaceutical Supply Chain Analysis
11.2 Blockchain In Pharmaceutical Key Raw Materials and Upstream Suppliers
11.3 Blockchain In Pharmaceutical Clients Analysis
11.4 Blockchain In Pharmaceutical Sales Channel and Sales Model Analysis
11.4.1 Blockchain In Pharmaceutical Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Blockchain In Pharmaceutical Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Blockchain In Pharmaceutical Distributors
12 Blockchain In Pharmaceutical Market Dynamics
12.1 Blockchain In Pharmaceutical Industry Trends
12.2 Blockchain In Pharmaceutical Market Drivers
12.3 Blockchain In Pharmaceutical Market Challenges
12.4 Blockchain In Pharmaceutical Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Blockchain In Pharmaceutical Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Blockchain In Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Blockchain In Pharmaceutical Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Blockchain In Pharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Blockchain In Pharmaceutical Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Blockchain In Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Blockchain In Pharmaceutical Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Blockchain In Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Blockchain In Pharmaceutical Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Blockchain In Pharmaceutical Revenue by Company (2020-2025) & (US$ Million)
Table 11. Blockchain In Pharmaceutical Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Blockchain In Pharmaceutical Players by Revenue (US$ Million) in 2024
Table 13. Global Blockchain In Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Blockchain In Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blockchain In Pharmaceutical as of 2024)
Table 15. Global Blockchain In Pharmaceutical Companies Headquarters
Table 16. Date of International Companies Enter into Blockchain In Pharmaceutical Market
Table 17. Global Blockchain In Pharmaceutical Companies Product & Service
Table 18. Global Blockchain In Pharmaceutical Mergers & Acquisitions, Expansion Plans
Table 19. IBM Corporation Information
Table 20. IBM Description and Business Overview
Table 21. IBM Blockchain In Pharmaceutical Product
Table 22. IBM Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. IBM Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 24. IBM Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 25. IBM Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 26. IBM Recent Developments
Table 27. AWS Corporation Information
Table 28. AWS Description and Business Overview
Table 29. AWS Blockchain In Pharmaceutical Product
Table 30. AWS Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. AWS Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 32. AWS Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 33. AWS Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 34. AWS Recent Developments
Table 35. Microsoft Corporation Information
Table 36. Microsoft Description and Business Overview
Table 37. Microsoft Blockchain In Pharmaceutical Product
Table 38. Microsoft Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Microsoft Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 40. Microsoft Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 41. Microsoft Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 42. Microsoft Recent Developments
Table 43. SAP Corporation Information
Table 44. SAP Description and Business Overview
Table 45. SAP Blockchain In Pharmaceutical Product
Table 46. SAP Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. SAP Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 48. SAP Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 49. SAP Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 50. SAP Recent Developments
Table 51. Chronicled Corporation Information
Table 52. Chronicled Description and Business Overview
Table 53. Chronicled Blockchain In Pharmaceutical Product
Table 54. Chronicled Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Chronicled Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 56. Chronicled Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 57. Chronicled Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 58. Chronicled Recent Developments
Table 59. Embleema Corporation Information
Table 60. Embleema Description and Business Overview
Table 61. Embleema Blockchain In Pharmaceutical Product
Table 62. Embleema Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Embleema Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 64. Embleema Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 65. Embleema Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 66. Embleema Recent Developments
Table 67. FarmaTrust Corporation Information
Table 68. FarmaTrust Description and Business Overview
Table 69. FarmaTrust Blockchain In Pharmaceutical Product
Table 70. FarmaTrust Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. FarmaTrust Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 72. FarmaTrust Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 73. FarmaTrust Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 74. FarmaTrust Recent Developments
Table 75. Guardtime Federal Corporation Information
Table 76. Guardtime Federal Description and Business Overview
Table 77. Guardtime Federal Blockchain In Pharmaceutical Product
Table 78. Guardtime Federal Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Guardtime Federal Revenue Proportion of Blockchain In Pharmaceutical by Product in 2024
Table 80. Guardtime Federal Revenue Proportion of Blockchain In Pharmaceutical by Application in 2024
Table 81. Guardtime Federal Revenue Proportion of Blockchain In Pharmaceutical by Geographic Area in 2024
Table 82. Guardtime Federal Recent Developments
Table 83. North America Blockchain In Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 84. North America Blockchain In Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 85. North America Blockchain In Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
Table 86. North America Blockchain In Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
Table 87. Asia-Pacific Blockchain In Pharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 88. Asia-Pacific Blockchain In Pharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 89. Asia-Pacific Blockchain In Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
Table 90. Asia-Pacific Blockchain In Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
Table 91. Europe Blockchain In Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 92. Europe Blockchain In Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 93. Europe Blockchain In Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
Table 94. Europe Blockchain In Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
Table 95. Latin America Blockchain In Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 96. Latin America Blockchain In Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 97. Latin America Blockchain In Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
Table 98. Latin America Blockchain In Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
Table 99. Middle East and Africa Blockchain In Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 100. Middle East and Africa Blockchain In Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 101. Middle East and Africa Blockchain In Pharmaceutical Revenue by Type (2020-2025) & (US$ Million)
Table 102. Middle East and Africa Blockchain In Pharmaceutical Revenue by Application (2020-2025) & (US$ Million)
Table 103. Blockchain In Pharmaceutical Key Raw Materials, Industry Status and Trend
Table 104. Blockchain In Pharmaceutical Key Raw Materials and Upstream Suppliers
Table 105. Blockchain In Pharmaceutical Clients Status and Trend
Table 106. Blockchain In Pharmaceutical Typical Clients
Table 107. Blockchain In Pharmaceutical Distributors
Table 108. Blockchain In Pharmaceutical Market Trends
Table 109. Blockchain In Pharmaceutical Market Drivers
Table 110. Blockchain In Pharmaceutical Market Challenges
Table 111. Blockchain In Pharmaceutical Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Blockchain In Pharmaceutical Product Picture
Figure 2. Global Blockchain In Pharmaceutical Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Blockchain In Pharmaceutical Revenue Market Share by Type in 2024 & 2031
Figure 4. Private Blockchain Product Picture
Figure 5. Hybrid Blockchain Product Picture
Figure 6. Global Blockchain In Pharmaceutical Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Blockchain In Pharmaceutical Revenue Market Share by Application in 2024 & 2031
Figure 8. Supply Chain Logistics
Figure 9. Drug Safety
Figure 10. Clinical Trial Management
Figure 11. IOMT & Cyber Security
Figure 12. Blockchain In Pharmaceutical Report Years Considered
Figure 13. Global Blockchain In Pharmaceutical Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Blockchain In Pharmaceutical Market Size (2020-2031) & (US$ Million)
Figure 15. Global Blockchain In Pharmaceutical Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Blockchain In Pharmaceutical Revenue Market Share by Region (2020-2031)
Figure 17. Global Blockchain In Pharmaceutical Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Blockchain In Pharmaceutical Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Private Blockchain of Blockchain In Pharmaceutical Revenue Market Share by Application, 2024 VS 2031
Figure 20. Hybrid Blockchain of Blockchain In Pharmaceutical Revenue Market Share by Application, 2024 VS 2031
Figure 21. Blockchain In Pharmaceutical Revenue Share by Company (2024)
Figure 22. Blockchain In Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Private Blockchain Revenue Proportion by Company in 2024
Figure 24. Hybrid Blockchain Revenue Proportion by Company in 2024
Figure 25. North America Blockchain In Pharmaceutical Revenue 2020-2031 (US$ Million)
Figure 26. North America Blockchain In Pharmaceutical Revenue Market Share by Type (2020-2025)
Figure 27. North America Blockchain In Pharmaceutical Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Blockchain In Pharmaceutical Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Blockchain In Pharmaceutical Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Blockchain In Pharmaceutical Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Blockchain In Pharmaceutical Revenue Market Share by Application (2020-2025)
Figure 32. Europe Blockchain In Pharmaceutical Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Blockchain In Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 34. Europe Blockchain In Pharmaceutical Revenue Market Share by Type (2020-2025)
Figure 35. Europe Blockchain In Pharmaceutical Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Blockchain In Pharmaceutical Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Blockchain In Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Blockchain In Pharmaceutical Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Blockchain In Pharmaceutical Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Blockchain In Pharmaceutical Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Blockchain In Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Blockchain In Pharmaceutical Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Blockchain In Pharmaceutical Revenue Market Share by Application (2020-2025)
Figure 44. Blockchain In Pharmaceutical Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Blockchain In Pharmaceutical Raw Materials by Region in 2024
Figure 46. Blockchain In Pharmaceutical Distribution Channels
Figure 47. Global Blockchain In Pharmaceutical Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Blockchain In Pharmaceutical Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
